AstraZeneca and MedImmune are committed to supporting quality independent education that:

  • Meet an educational need by providing information designed to assist health care professionals in their efforts to enhance patient care
  • Further the understanding of emerging therapies based on a documented unmet need
  • Incorporate evidence-based medicine in the program objectives and methodology
  • Assist health care professionals in carrying out diagnosis and treatment strategies more effectively and efficiently
  • Support the efforts of health care professionals to broaden patient knowledge and awareness of disease states and treatment options
  • Address performance and quality improvement

We focus our support where there is the greatest need in areas that overlap with our areas of interest.

We have incorporated Call for Grant Applications into our process. Please check available Call for Grants below.

Available funding for areas of educational interest

No funding available - check back periodically

Areas of Educational Interest Available Funding Call for Grants
CARDIOVASCULAR    
Acute Coronary Syndrome    
High Risk Prior Myocardial Infarction    
Hypertriglyceridemia    
Heart Failure    
ENDOCRINOLOGY    
Type 1 Diabetes    
Type 2 Diabetes    
Type 2 Diabetes – Heart Failure    
Type 2 Diabetes – Chronic Kidney Disease    
MEDIMMUNE    
Research & Development Support    
NEPHROLOGY    
Chronic Kidney Disease – Anemia  
Hyperkalemia    
NEUROLOGY / PAIN    
Opioid-Induced Constipation    
ONCOLOGY    
Advanced Breast Cancer    
  • BRCA
   
  • Non-BRCA
   
  • DNA Damage Response
   
  • PARP inhibition
   
  • HER2+
   
  • Metastatic HR+
   
Ovarian Cancer    
  • BRCA
   
  • Non-BRCA
   
  • PARP inhibition
   
  • DNA Damage Response
   
Hematology    
  • CLL (Chronic Lymphocytic Leukemia)
   
  • MCL (Mantle Cell Lymphoma)
   
  • HCL (Hairy Cell Leukemia)
   
  • WM (Waldenstrom Macroglobulinemia)
   
Immuno-Oncology    
  • Bladder
   
  • imAE Management
   
  • Extensive-Stage SCLC
   
  • Non-Metastatic NSCLC
   
  • IO Diagnostics – Multidisciplinary Team
   
  • IO Lung Diagnostics – Staging
   
Neurofibromatosis    
Non Small Cell Lung Cancer    
  • EGFR – Multidisciplinary Team
   
  • EGFR Diagnostics – Staging
   
  • EGFR Diagnostics - Tissue Collection
   
  • EGFR Diagnostics - Plasma Testing
   
  • EGFRm+ NSCLC
   
  • EGFR T790m+ NSCLC
   
Pancreatic Cancer    
  • BRCA
   
  • DNA Damage Response
   
  • PARP Inhibition
   
Prostate Cancer (mCRPC)    
  • DNA Damage Response
   
  • Homologus Recombination Repair
   
  • PARP inhibition
   
RESPIRATORY    
COPD    
Asthma    
Severe Asthma    
RHEUMATOLOGY/IMMUNOLOGY/AUTOIMMUNE    
Systemic Lupus Erythematosus    
RESEARCH & DEVELOPMENT    
Scientific or educational activities designed to educate research scientists, principal researchers, drug development professionals, academics, pre-doctoral students, doctoral students and fellows. These programs must be educational and non-promotional in nature and planned, designed and implemented in accordance with the U.S. Food and Drug Administration's Guidance on Industry-Supported Scientific and Educational Activities